Enforcement Report for Week of June 28, 2023
The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg Due to Label Mix-up
Zydus Pharm’s Generic Ziprasidone Hydrochloride Receives Approval In US
Aurobindo's Generic Ziprasidone Hydrochloride Receives Approval In US
US FDA warns Pfizer antipsychotic linked to serious allergic reaction
FDA Drug Safety Communication: FDA Reporting Mental Health Drug Ziprasidone (Geodon) Associated with Rare but Potentially Fatal Skin Reactions